Professional Documents
Culture Documents
Anal Cancer: NCCN Guidelines For Patients
Anal Cancer: NCCN Guidelines For Patients
Anal Cancer: NCCN Guidelines For Patients
GUIDELINES
FOR PATIENTS
®
2021
Anal Cancer
Presented with support from:
It's easy to
get lost in the
cancer world
Let
NCCN Guidelines
for Patients®
be your guide
Step-by-step guides to the cancer care options likely to have the best results
National Comprehensive
Cancer Network®
These NCCN Guidelines for Patients are based on the NCCN Guidelines® for Anal Cancer, Version 1.2021 —
February 16, 2021.
© 2021 National Comprehensive Cancer Network, Inc. All rights reserved. NCCN Foundation seeks to support the millions of patients and their families
NCCN Guidelines for Patients and illustrations herein may not be reproduced in
any form for any purpose without the express written permission of NCCN. No Patients. NCCN Foundation is also committed to advancing cancer treatment
one, including doctors or patients, may use the NCCN Guidelines for Patients for by funding the nation’s promising doctors at the center of innovation in cancer
any commercial purpose and may not claim, represent, or imply that the NCCN research. For more details and the full library of patient and caregiver resources,
visit NCCN.org/patients.
from, based on, related to, or arise out of the NCCN Guidelines for Patients.
National Comprehensive Cancer Network (NCCN) / NCCN Foundation
3025 Chemical Road, Suite 100
kind whatsoever regarding its content, use, or application and disclaims any Plymouth Meeting, PA 19462
responsibility for its application or use in any way. 215.690.0300
Supporters
Sponsored by
Endorsed by
HPV Alliance
The HPV Alliance mission is to be a leading resource to empower
individuals with knowledge about the impact of HPV infections on
health and lifestyle to embolden them to take action to prevent, limit
spread, and treat HPV infections to eliminate the risk of developing
HPV related cancers, like anal cancer. HPVAlliance.org
Contents
6 Anal cancer basics
17 Treatment guide
32 Survivorship
52 Words to know
53 NCCN Contributors
56 Index
The anus
“
section of the large intestine. In the colon,
water is absorbed from unused food, turning it
into stool. Stool is then held in the last several
inches of the large intestine, called the rectum,
until it exits the body through the anus.
Because anal cancer is rare and
Anal cancer starts in either the anal canal or stigmatized, it is harder to find
the perianal region. The anal canal connects
the rectum and the anal opening. It is about others who have been through it.
1 and a half inches (4 centimeters) long. The Get yourself a mentor, and when
anal canal is surrounded by muscles (anal
you recover, pay it forward by
sphincters) that relax to allow stool to leave
the body through the anus. The perianal mentoring someone else.
region includes the anal opening and the skin
directly surrounding it. In some cases, an anal
tumor can involve both the anal canal and the – Michael
perianal region. Anal cancer survivor
Risk factors which can make it harder for the body to clear
HPV infection.
A risk factor is something that increases the
risk of developing a disease. Some people
with no known risk factors get anal cancer. virus (HIV)
And, some people with risk factors never get
Taking anti-rejection medicines
anal cancer. Risk factors for anal cancer are
(immunosuppressants) after an organ
described next.
transplant
A history of cervical, vulvar, or vaginal
Human papillomavirus infection
cancer or precancer
The risk factor most strongly linked with anal
cancer is long-term infection with human A history of anal precancer
papillomavirus (HPV). HPV is a sexually
A history of blood cancer such as
transmitted virus. HPV is extremely common.
lymphoma (Hodgkin or non-Hodgkin),
chronic lymphocytic leukemia, or multiple
sexually active. Most people are unaware that
myeloma
they are–or ever were–infected.
Certain autoimmune disorders, such as
In most people, the immune system gets Crohn’s disease
rid of (“clears”) HPV from the body. In some
Smoking
people, however, the virus causes long-term
cell changes that develop into cancer. The A history of anal sex or sexually
progression to cancer often occurs decades transmitted infection
after the initial infection. Doctors are still
learning why one person gets anal cancer and
Risk reduction
another does not. Cancers caused by HPV
Anal cancer starts as areas of abnormal
include anal, cervical, head and neck, penile,
cells, called lesions, in or near the anus.
vaginal, and vulvar cancers.
These pre-cancerous lesions are known as
anal dysplasia. Identifying and treating anal
There are more than 100 types (called strains)
dysplasia may prevent anal cancer.
of HPV. Infection with some strains is more
likely to lead to anal cancer and other related
Other names for anal dysplasia include:
cancers. High-risk forms of HPV include HPV-
16 and HPV-18. HPV infection can also cause
Low-grade squamous intraepithelial lesion
abnormal skin growths, called warts, to form
(LSIL) (mild dysplasia)
on the anus or genitals.
High-grade squamous intraepithelial
lesion (HSIL) (moderate or severe
Other risk factors
dysplasia)
The health- and lifestyle-related factors listed
below can also increase the risk of anal Anal intraepithelial neoplasia (AIN)
cancer. Some of these factors lead to a higher
Stage 0 anal cancer
risk because they weaken the immune system,
CT scans
A CT scan of the
chest and abdomen
with contrast is
recommended to look
for areas of cancer
beyond the pelvis, such
as the liver or lungs.
Either CT or MRI is
used to learn the extent
of anal cancer in the
pelvis.
Lymph nodes cannot usually be seen or felt in either computed tomography (CT) or magnetic
the early stages of cancer, but may become resonance imaging (MRI) is recommended.
enlarged as cancer progresses. Your doctor will To look for areas of cancer beyond the pelvis,
examine lymph nodes in the groin by pressing a CT scan of the chest and abdomen with
on the surface of the skin. This is known as contrast is recommended. In some cases,
palpation. If any lymph nodes feel enlarged positron emission tomography (PET) may be
or look suspicious on imaging tests, a sample combined with a CT or MRI. CT, MRI, and PET
may be removed for testing. A thin needle may are described below.
be used to remove a sample of tissue from the
CT takes many pictures of areas inside of
(FNA). In some cases, all or part of a lymph the body using x-rays. A computer combines
node may be removed by cutting into the skin. the x-rays to make one detailed picture.
This is called an excisional biopsy. The picture is saved for later viewing by a
radiologist. You will lie face-up on a table that
Imaging moves through a tunnel-like machine.
Imaging for anal cancer allows your doctors
to see areas inside the body in detail. Imaging A substance called contrast will be used to
tests provide information on the extent of the make the pictures clearer. Before the CT scan,
cancer and whether it has spread to distant you will be asked to drink a large glass of oral
areas (metastasized). contrast. A contrast agent will also be injected
To learn the extent of anal cancer in the anus or get hives. Rarely, serious allergic reactions
and nearby areas (including lymph nodes), occur. Tell your doctors if you have had bad
MRI
Stage III
Stage III anal cancer is divided into 3 sub-
“
stages. There may be cancer in nearby lymph
nodes.
Stage IV
The cancer is metastatic. This means it has
spread to areas beyond the pelvis, such as
the liver or lungs. Stage IV anal cancer is
described as T (may be 1, 2, 3, or 4), N (0 or
1), M1.
Fertility and family planning For more information on this topic, see the
NCCN Guidelines for Patients: Adolescents
Anal cancer treatment almost always involves and Young Adults with Cancer at NCCN.org/
radiation therapy. Radiation therapy can cause patientguidelines.
or contribute to infertility, which is the inability
to produce children. If you want the option of
having children after treatment or are unsure,
tell your doctor. There are ways to be able to
have children after cancer treatment. This is
called fertility preservation.
Sperm banking
Sperm banking stores semen for later use by
freezing it in liquid nitrogen. The medical term
for this is semen cryopreservation.
Egg freezing
Like sperm banking, unfertilized eggs can
be removed, frozen, and stored for later
use. The medical term for this is oocyte
cryopreservation.
Ovarian transposition
This procedure moves one or both ovaries and
fallopian tubes out of the range of the radiation
beam. The medical term for this procedure is
oophoropexy.
“
Key points
The anus is the opening at the bottom of
the large intestine through which feces
(stool) exit the body. It is located in the No questions are too silly. If
pelvis.
your doctor is dismissive of your
Anal cancer starts in either the anal canal
questions/concerns, get another
or the perianal region. The anal canal is
the small section of intestine between the doctor.
rectum and the anus. The perianal region
includes the anal opening and the skin
directly surrounding it. – Diane
Anal cancer starts in either the anal All types of EBRT are conformal, which means
canal or the perianal region. Treatment that the radiation beams are shaped to the
with chemotherapy and radiation tumor. What makes IMRT unique compared
(chemoradiation) is recommended for to other forms of EBRT is that it uses many
most non-metastatic anal cancers.
Surgery to remove the anus may This allows a high dose of radiation to be
targeted at the tumor while limiting the amount
be needed for cancer that does not
of radiation to the surrounding normal tissue.
respond to treatment or that returns With IMRT it is possible to reduce radiation to
after treatment. Metastatic anal cancer important nearby organs and structures, such
is treated with systemic therapy. as external genitalia and hip joints. This can
see, hear, and speak with you at all times. As Radiation therapy for anal cancer can also
treatment is given, you may hear noises. You have long-term and potentially serious side
will not see, hear, or feel the radiation. One
session can take less than 10 minutes. and bladder function. See “Fertility and family
planning” on page 15 and Part 3: Survivorship
for information on ways to help prevent, limit,
Radiation therapy
An advanced radiation
technique called
intensity-modulated
radiation therapy (IMRT)
is the preferred method
for treating anal cancer.
Currently recommended chemotherapy infuses the medicine into the body very
regimens for use with radiation therapy to treat slowly, over several days. The tube, called a
stage I, II, and III anal cancer include: central venous catheter, stays in place for the
duration of treatment. It allows you to receive
Mitomycin and capecitabine chemotherapy with 5-FU from home.
Mitomycin and 5-FU
5-FU and cisplatin therapy begins and lasts for 4 to 5 days. You
will have another 4- to 5-day infusion at the
While you undergo chemotherapy with one start of week 5 of radiation therapy. The pump
of the above regimens, you will also receive will be disconnected and removed between
treatment with radiation therapy 5 days per infusions.
week. These chemotherapy regimens are
described in more detail next.
tube will be inserted into a vein in your upper chemotherapy regimens discussed above
chest, below the collarbone. This is referred are nausea, vomiting, severe diarrhea, sores
to as a “port.” Using a small wire and often in the mouth and lining of the anus, and low
x-ray guidance, the tube is guided to a large blood cell counts. Low white blood cell counts
vein above the right side of the heart called can make you prone to infections. Talk to
the superior vena cava. Some people receive your treatment team about ways to prevent or
a temporary PICC line instead. A PICC line is
a deep IV that stays in the arm for the duration
of treatment.
as hand-foot syndrome. Symptoms include
The 5-FU is stored in a small, wearable redness, swelling, and pain on the palms of
pump connected to the catheter. The pump the hands, bottoms of feet, or both. Sometimes
Local excision
Local excision is a recommended treatment
option for some:
Stage I perianal cancers
Stage IIA perianal cancers that have not
We want your invaded the sphincter muscle
(intermediate grade)
Chemoradiation
Chemoradiation is recommended for all non-
metastatic perianal cancers that do not meet
the criteria for local excision. This includes:
Local excision should only be considered
for low-grade (G1) and intermediate-grade
Fast-growing (high-grade) stage I and II
(G2) perianal cancers.
cancers
The normal tissue surrounding the lesion Stage II cancers that have invaded the
removed during surgery is called the surgical sphincter
margin.
Stage III cancers
If a margin of at least 1 cm is removed and
Chemoradiation treatment for perianal cancer
it does not contain cancer cells, no further
is the same as for anal canal cancer. See
treatment is needed. The cancer will be
“Anal canal cancer” on page 18 for treatment
observed. See Follow-up and surveillance on
information.
page 23 for next steps.
Next steps
If a margin of less than 1 cm is removed
See Follow-up and surveillance on page 23 for
or if the tissue contains cancer cells, more
next steps.
treatment is needed. The preferred next
treatment is another surgery (re-excision).
Another option is radiation therapy with or
without chemotherapy. If this treatment option
is planned, chemotherapy regimens that may
be used with radiation include:
Next steps
See Follow-up and surveillance on page 23 for
next steps.
Anoscopy
Anoscopy is recommended every 6 to 12
months for 3 years after treatment.
“
Progressive disease
If the follow-up examination 8 to 12 weeks
Removing the anus means there is no natural cancer that returns to the inguinal (groin)
way for stool to exit the body. A permanent lymph nodes. Chemotherapy with one of the
colostomy is needed. A colostomy connects following regimens may be given in addition to
the end of the colon to the outside of the radiation:
abdomen. This creates an opening, called a
stoma, on the surface of the abdomen. Stool Mitomycin and capecitabine
exits the body through the stoma and goes into
5-FU and mitomycin
a bag attached to the skin.
This section provides recommendations for Ask your treatment team to explain:
treating anal cancer that has spread beyond
the pelvis. If anal cancer metastasizes, it How often you need to receive
spreads most often to the liver or lungs. chemotherapy
Metastatic anal cancer is treated with
How long you need to receive
chemotherapy.
chemotherapy
Treatment with radiation therapy in addition How chemotherapy treatment will be
to chemotherapy is an option for cancer that given (eg, intravenously, orally, infusion
metastasized before it was diagnosed (stage pump)
IV anal cancer) and that has therefore never
been treated with radiation. If there is a limited
number of small metastases, a special type
of radiation therapy called stereotactic body
chemotherapy regimens discussed above
radiation therapy (SBRT) may be used.
are nausea, vomiting, diarrhea, hair loss, and
sores in the mouth and lining of the anus.
If the cancer metastasizes after initial
treatment that included radiation, radiation
Platinum-based chemotherapy medicines,
therapy cannot be used again to treat the
including carboplatin, cisplatin, and oxaliplatin,
same areas. Palliative radiation therapy
can damage the kidneys. Many people cannot
may be an option if the cancer is causing
have cisplatin because their kidneys do not
symptoms. Palliative radiation therapy can
work well or because of other health issues.
limit the size of the tumor(s) and help with
symptoms. If palliative radiation is planned,
receiving platinum-based chemotherapy
care will be taken to ensure that areas initially
may receive routine IV hydration. Cisplatin
treated with radiation are not treated a second
may also cause hearing problems or hearing
time.
loss. Oxaliplatin can cause nerve damage
Metastatic anal cancer is treated with platinum-
numbness, cramping, tingling, or pain in these
based chemotherapy. Currently recommended
areas.
regimens include:
Ask your treatment team for a complete list of
Carboplatin and paclitaxel
5-FU, leucovorin, and oxaliplatin medicine you are receiving. There are ways to
(FOLFOX)
5-FU, leucovorin, and cisplatin (FOLFCIS)
Progression
If the cancer progresses during or after
(DCF)
treatment with chemotherapy, immunotherapy
“Stay calm, take care of your mental and emotional self, get organized,
and be prepared to be your own advocate. Ask the hard questions. Start a
notebook and take it to all appointments to note what is said and how you
are doing along the way. I even asked if I could record some of those early
appointments so I could play them back later.
– Thom
Anal cancer survivor
cancer.
Frequently asked questions
Phase III trials test the drug or approach There are many myths and misconceptions
against a standard treatment. If the surrounding clinical trials. The possible
results are good, it may be approved by
the FDA. many with cancer.
Phase IV trials study the long-term
What if I get the placebo?
A placebo is an inactive version of a real
treatment.
medicine. Placebos are almost never used
alone in cancer clinical trials. All participants
Who can enroll? receive cancer treatment. You may receive a
Every clinical trial has rules for joining, called commonly used treatment, the investigational
eligibility criteria. The rules may be about age, drug(s), or both.
“
In the United States
NCCN Cancer Centers
NCCN.org/cancercenters
– Melissa
NCI’s Cancer Information Service (CIS)
Anal cancer survivor 1.800.4.CANCER (1.800.422.6237)
cancer.gov/contact
37 Healthy habits
38 More information
Survivorship focuses on the physical, Clear roles and responsibilities for both
your cancer care team and your PCP
to cancer survivors. Managing the
Recommendations on your overall health
and well-being
its treatment, staying connected with
your primary care doctor, and living a
healthy lifestyle are important parts of
survivorship.
primary care doctor, also known as a general commonly reported changes in bowel habits
practitioner (GP) or primary care physician include:
(PCP) will play an important role in your care.
Your oncologist (cancer doctor) and PCP An inability to control bowel movements
should work together to make sure you get the (fecal incontinence)
follow-up care you need. Your oncologist will
Increase in bowel movements
develop a written survivorship care plan that
includes:
Urgent need to pass stool (fecal urgency)
A summary of your cancer treatment
history, including surgeries, radiation Watery stool
treatments, and chemotherapy
Urinary incontinence (the inability to hold urine
A description of possible short-term, late,
in the bladder) and urgency are also possible
after radiation therapy for anal cancer. There
Recommendations for monitoring for the are ways to control or lessen these symptoms.
return of cancer Over-the-counter anti-diarrheal medicine
can help with frequent and watery bowel
Information on when your care will be
movements, as it thickens stool.
transferred to your PCP
Mental health and wellness excellent resources to help connect you with
report having an overall lower quality of life For more information see the NCCN
Guidelines for Patients: Distress During
on bowel, bladder, and sexual function, Cancer Care at NCCN.org/patientguidelines.
Peer-to-Peer support
“
Ostomy care
If you have an ostomy, you may want to join
an ostomy support group. Another option is
to see a health care provider that specializes
You will get through this. It might
in ostomy care, such as an ostomy nurse.
People with ostomies can still live very active seem hard at times toward the
lifestyles. However, it’s a good idea to consult end of treatment and the following
with an ostomy professional before any
vigorous or high-intensity physical activity. weeks and months while you
recover, but it will pass. I tried to
just stay focused on the goal of
getting through to the other side to
whatever comes next.
– Thom
Anal cancer survivor
Ostomy
Get screened for other types of cancer, such Radiation treatment to the pelvis can weaken
as breast, cervical, colorectal, or prostate bones in the pelvis, putting you at increased
cancer. Your primary care doctor should tell risk of fractures. Your doctor may want to start
you what cancer screening tests you should monitoring the density of your bones.
have based on your gender, age, and risk
level. Drink little to no alcohol. This means no more
than 1 drink/day for women, and no more than
Get other recommended health care such 2 drinks/day for men.
as blood pressure screening, hepatitis C
If you are a smoker, quit! Your doctor will be
shot). able to provide (or refer you for) counseling on
how to stop smoking.
Leading a healthy lifestyle includes maintaining
a healthy body weight. Try to exercise at a
5. When will I have a biopsy? What type of biopsy? What are the risks?
7. What tests are needed? What other tests do you recommend? Will I have any genetic
tests?
8. How do I prepare for testing? How and where will the test be done?
9. How soon will I know the results and who will explain them to me?
10. Is there a portal where I can get copies of my test results and other records?
11. Who will talk with me about the next steps? When?
12. Will treatment start before the test results are in?
4. Do you consult the NCCN Clinical Practice Guidelines in Oncology® when considering
treatment options?
5. Are you suggesting options other than what NCCN recommends? If yes, why?
6.
7.
treatment?
8. What if I am pregnant? What if I’m planning to get pregnant in the near future?
10. Which option is proven to work best for my cancer subtype, age, and other risk factors?
11.
one option than another? Less time-consuming? Less expensive?
12. Which treatment will give me the best quality of life? Which treatment will extend life? By
how long?
2. Do I have a choice of when to begin treatment? Can I choose the days and times of
treatment?
3. How much will this treatment cost? What does my insurance cover? Are there any
programs to help pay for treatment?
5. What in particular should be avoided or taken with caution while receiving treatment?
12. Can I stop treatment at any time? What will happen if I stop treatment?
1.
2.
3.
over time?
5.
6.
7.
for?
8.
9.
10.
7. How many patients like me (of the same age, gender, race) have you treated?
8. Will you be consulting with experts to discuss my care? Whom will you consult?
9. How many procedures like the one you’re suggesting have you done?
10. How many of your patients have had complications? What were the complications?
3.
6. How many treatment sessions will I require? Can you do a shorter course of radiation?
7.
8.
9. Will I need to take steps to ensure the safety of others in my household after radiation
treatment?
2.
4. How much pain will I be in? What will be done to manage my pain?
6.
this surgery?
9. How often will I need check-ups after surgery? What are the chances that the cancer will
come back?
10. What happens if all of the cancer cannot be removed during surgery?
2. What clinical trials are available? Am I eligible for any of them? Why or why not?
5. Has the treatment been used before? Has it been used for other types of cancer?
6.
7.
11. Will the clinical trial cost me anything? If so, how much?
2. What are the chances the cancer will return or I will get another type of cancer?
3. Whom do I see for follow-up care? How often? For how many years?
4. What should I do if I have trouble paying for follow-up visits and tests?
5. What tests will I have to monitor my health? Who is responsible for scheduling them?
6.
7. I am looking for a survivor support group. What support groups or other resources can
you recommend?
8. What happens if I move after treatment and have to change doctors? Will you help me
Websites
Cancer.Net
cancer.net/cancer-types/anal-cancer Take our survey
And help make the
CancerCare NCCN Guidelines for Patients
www.Cancercare.org better for everyone!
NCCN.org/patients/comments
Cancer Support Community
cancersupportcommunity.org
HPV Alliance
hpvalliance.org/
NCCN Contributors
This patient guide is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Anal Cancer, Version
1.2021 — February 16, 2021. It was adapted, reviewed, and published with help from the following people:
Dorothy A. Shead, MS Laura J. Hanisch, PsyD John Murphy
Senior Director Medical Writer/Patient Information Specialist Medical Writer
Patient Information Operations
Stephanie Helbling, MPH, CHES ®
Erin Vidic, MA
Rachael Clarke Medical Writer Medical Writer
Senior Medical Copyeditor
Susan Kidney Kim Williams
Tanya Fischer, MEd, MSLIS Graphic Design Specialist Creative Services Manager
Medical Writer
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Anal Cancer, Version 1.2021 — February 16, 2021 were
developed by the following NCCN Panel Members:
Al B. Benson, III, MD/Chair Hitendra Patel, MD
UC San Diego Moores Cancer Center
Center of Northwestern University
Joleen Hubbard, MD Katrina S. Pedersen, MD, MS
Alan P. Venook, MD/Vice-Chair Mayo Clinic Cancer Center Siteman Cancer Center at Barnes-
UCSF Helen Diller Family Jewish Hospital and Washington
Comprehensive Cancer Center Steven Hunt, MD University School of Medicine
Siteman Cancer Center at Barnes-
Mahmoud M. Al-Hawary, MD Jewish Hospital and Washington *Leonard Saltz, MD
University of Michigan Rogel Cancer Center University School of Medicine Memorial Sloan Kettering Cancer Center
Mustafa A. Arain, MD *Kimberly L. Johung, MD, PhD Charles Schneider, MD
UCSF Helen Diller Family Yale Cancer Center/Smilow Cancer Hospital
Comprehensive Cancer Center at the University of Pennsylvania
Natalie Kirilcuk, MD
*Yi-Jen Chen, MD, PhD Stanford Cancer Institute David Shibata, MD
City of Hope National Medical Center The University of Tennessee
Smitha Krishnamurthi, MD Health Science Center
Kristen K. Ciombor, MD Case Comprehensive Cancer Center/
University Hospitals Seidman Cancer Center
and Cleveland Clinic Taussig Cancer Institute
John M. Skibber, MD
Stacey Cohen, MD The University of Texas
Fred Hutchinson Cancer Research Center/ Wells A. Messersmith, MD MD Anderson Cancer Center
Seattle Cancer Care Alliance University of Colorado Cancer Center
Constantinos T. Sofocleous, MD, PhD
Harry S. Cooper, MD Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
Cancer Center
Dustin Deming, MD University of Michigan Rogel Cancer Center
University of Wisconsin Eric D. Miller, MD, PhD
The Ohio State University Comprehensive
Eden Stotsky-Himelfarb, BSN, RN
The Sidney Kimmel Comprehensive
Cancer Center - James Cancer Hospital
*Linda Farkas, MD and Solove Research Institute
UT Southwestern Simmons
Comprehensive Cancer Center Mary F. Mulcahy, MD Christopher G. Willett, MD
Notes
Index
abdominoperineal resection (APR) 25–26,
31, 47, 52
anal dysplasia 9–10, 13
clinical trials 29–31, 48
dietitian 34
distress 35, 38
fertility 15, 19, 42
11
high-resolution anoscopy (HRA) 10, 41
HIV 9, 12, 16
HPV 7, 9, 12–13, 16, 52
immunotherapy 27–28, 31
intensity-modulated radiation therapy
(IMRT) 18–19, 31
mental health 35
nutrition 34
Pap test 11–12
risk factors 9, 16
sexual health 34
stereotactic body radiation therapy (SBRT)
27
carcinoma (SISCCA) 10
survivorship 33
vaginal dilator 34
vaginal stenosis 34
Anal Cancer
2021
NCCN Foundation gratefully acknowledges our corporate supporters, Amgen Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol
Myers Squibb; Sirtex Medical, Inc.; and Taiho Oncology, Inc.; and our advocacy supporter, Anal Cancer Foundation for helping to make
available these NCCN Guidelines for Patients. These NCCN Guidelines for Patients are also supported in part by an educational grant
from Bayer HealthCare Pharmaceuticals Inc. NCCN independently adapts, updates, and hosts the NCCN Guidelines for Patients. Our
corporate supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content
and recommendations contained therein.
PAT-N-1403-0621